Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension Review article

Main Article Content

Piotr Jędrusik

Abstract

The ACCOMPLISH study compared combined treatment with benazepril-amlodypine and benazepril-hydrochlorthiazide in hypertensive patients at high risk of cardiovascular events. The use of benazepril-amlodipine combination resulted in reduced cardiovascular morbidity and mortality compared to treatment with benazepril and hydrochlorthiazide despite similar blood pressure reduction in both study groups.

Downloads

Download data is not yet available.

Article Details

How to Cite
Jędrusik , P. (2009). Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension. Cardiology in Practice, 3(1), 23-25. Retrieved from https://journalsmededu.pl/index.php/kwp/article/view/1667
Section
Articles

References

1. Jamerson K., Weber M.A., Bakris G.L. et al.: Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N. Engl. J. Med. 2008, 359: 2417-2428.
2. Chobanian A.V.: Does it matter how hypertension is controlled? N. Engl. J. Med. 2008, 359: 2485-88.
3. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288: 2981-2997.